Reference number : 236-2017-2018-Q4-00316, amendment number : , agreement type : G, recipient legal name : Lang, Anthony E, recipient country : CA, recipient province : ON, recipient city : Toronto, recipient postal code : M5G 2C4, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 160650.0, agreement start date : 2018-04-01, agreement end date : 2019-03-31, description english : Preclinical efficacy of drugs predicted by IBM-Watson artificial intelligence for repurposing to treat L-DOPA-induced dyskinesia, description french : Preclinical efficacy of drugs predicted by IBM-Watson artificial intelligence for repurposing to treat L-DOPA-induced dyskinesia, expected results english : nan, expected results french : nan, additional information english : nan, additional information french : nan, owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada